Related Experiment Video
Updated: Jun 18, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Hospitalization rate for ulcerative colitis and Crohn's disease in Brazil and its correlation with socioeconomic
Jenny Diniz Malentaqui Lousada1,2, Carla Peluso3,4, Bianca Bianco3,4
1Epidemiology and Data Analysis Laboratory, Centro Universitário FMABC, Santo André, São Paulo, Brazil.
Abstract:
INTRODUCTION: Inflammatory bowel diseases (IBD), mainly represented by Crohn’s disease and ulcerative colitis, have a multifactorial etiology and a growing incidence in developing countries. In Brazil, studies on their occurrence and relationship with social conditions remain scarce, which reinforces the importance of updated epidemiological analyses. METHOD: Ecological study using secondary data on hospital admissions extracted from the Hospital Information System of the Brazilian Unified Health System (SIH/SUS). Population data were obtained from the Brazilian Institute of Geography and Statistics (IBGE), and socioeconomic indicators (HDI-M, SVI, and Gini Index) from the Institute for Applied Economic Research (IPEA). Incidence rates were age-standardized according to the WHO world standard population. For time trend analysis, Prais-Winsten linear regression was applied, and to assess relationships with socioeconomic variables, linear regression analysis was used. The statistical software employed was Stata version 18.0. RESULTS: Between 2010 and 2023, there were 64,303 hospital admissions for IBD in Brazil. The highest frequency was observed among women, adults aged 20 to 59 years, and in the Southeast region, while the lowest occurred in the North region. Regarding incidence, there was a significant increase among men, individuals under 19 years old, adults aged 20 to 59 years, and in the Northeast and Southeast regions. Nationally, an annual growth of 2% in incidence was observed. No significant associations were found with socioeconomic indicators, but regional analyses revealed important relationships with HDI-M and SVI. CONCLUSION: The results demonstrate an increase in hospital admissions for IBD in Brazil, particularly among younger groups and in specific regions, indicating changes in the epidemiological profile. These findings highlight the need for public policies focused on early diagnosis, equitable access to specialized services, and the strengthening of epidemiological surveillance. Future research should explore environmental, nutritional, and social factors that may influence the occurrence and progression of IBD.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

